Emcure says it will continue growth momentum in FY21 by deepening product portfolio, digital focus

Emcure says it will continue growth momentum in FY21 by deepening product portfolio, digital focus The privately held Pune-based company aims to first bring generic drugs to the market through the company’s own RD efforts and innovative molecules through licensing

No comments:

Post a Comment